ArticleJAMA network open2024

Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease.

Keiichi Sumida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.